DEFINITIVE PROXY STATEMENT

Company

Aptose Biosciences Inc.

Filed

April 20, 2022

Period of Report

May 31, 2022

Accession Number

0001171843-22-002658

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →